The­o­ret­i­cal­ly speak­ing, it’s pos­si­ble for vac­cine mak­ers to split up the measles, mumps and rubel­la vac­cines, as re­cent­ly or­dered by Pres­i­dent Don­ald Trump.

Prac­ti­cal­ly speak­ing...

A group of ex­perts on Prad­er-Willi syn­drome has sound­ed the alarm on side ef­fects and deaths that may be con­nect­ed to Neu­ro­crine Bio­sciences’ med­i­cine Vykat...

Eli Lil­ly has sued six US com­pa­nies for sell­ing what it claims is the phar­ma gi­ant’s in­ves­ti­ga­tion­al di­a­betes and weight loss drug re­ta­tru­tide, which is...

From 2028 to 2032, gener­ic drug ap­pli­cants will con­tin­ue to see many of the same FDA re­view time­lines as they did over the last five...

Last week, we host­ed the most en­gag­ing event I’ve been a part of here at End­points News.

If you were there, you got to...

Defini­um Ther­a­peu­tics said Wednes­day its oral LSD can­di­date has passed a late-stage study in gen­er­al­ized anx­i­ety dis­or­der (GAD), not even two months af­ter re­port­ing tri­al...